Literature DB >> 33358838

Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.

Anubha Agarwal1, Padinhare P Mohanan2, Dimple Kondal3, Abigail Baldridge4, Divin Davies2, Raji Devarajan3, Govindan Unni5, Jabir Abdullakutty6, Syam Natesan7, Johny Joseph8, Pathiyil B Jayagopal9, Stigi Joseph10, Rajesh Gopinath11, Mark D Huffman12, Dorairaj Prabhakaran13.   

Abstract

BACKGROUND: Although quality improvement interventions for acute heart failure have been studied in high-income countries, none have been studied in low- or middle-income country settings where quality of care can be lower. We evaluated the effect of a quality improvement toolkit on process of care measures and clinical outcomes in patients hospitalized for acute heart failure in 8 hospitals in Kerala, India utilizing an interrupted time series design from February 2018 to August 2018.
METHODS: The quality improvement toolkit included checklists, audit-and-feedback reports, and patient education materials. The primary outcome was rate of discharge guideline-directed medical therapy for patients with heart failure with reduced ejection fraction. We used mixed effect logistic regression and interrupted time series models for analysis.
RESULTS: Among 1400 participants, mean (SD) age was 66.6 (12.2) years, and 38% were female. Mean (SD) left ventricular ejection fraction was 35.2% (9.7%). The primary outcome was observed in 41.3% of participants in the intervention period and 28.1% of participants in the control period (difference 13.2%; 95% CI 6.8, 19.0; adjusted OR = 1.70; 95% CI 1.17, 2.48). Interrupted time series model demonstrated highest rate of guideline-directed medical therapy at discharge in the initial weeks following intervention delivery with a concomitant decline over time. Improvements were observed in discharge process of care measures, including diet counseling, weight monitoring instructions, and scheduling of outpatient clinic follow-up but not hospital length of stay nor inpatient mortality.
CONCLUSIONS: Higher rates of guideline-directed medical therapy at discharge were observed in Kerala. Broader implementation of this quality improvement intervention may improve heart failure care in low- and middle-income countries.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heart failure; India.; Quality improvement.

Mesh:

Year:  2020        PMID: 33358838      PMCID: PMC8059774          DOI: 10.1016/j.ijcard.2020.12.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  26 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure.

Authors:  Adam D DeVore; Margueritte Cox; Paul A Heidenreich; Gregg C Fonarow; Clyde W Yancy; Zubin J Eapen; Eric D Peterson; Adrian F Hernandez
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-07-14

3.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

4.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

5.  Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial.

Authors:  Mark D Huffman; Padinhare P Mohanan; Raji Devarajan; Abigail S Baldridge; Dimple Kondal; Lihui Zhao; Mumtaj Ali; Mangalath N Krishnan; Syam Natesan; Rajesh Gopinath; Sunitha Viswanathan; Joseph Stigi; Johny Joseph; Somanathan Chozhakkat; Donald M Lloyd-Jones; Dorairaj Prabhakaran
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

6.  Global and regional patterns in cardiovascular mortality from 1990 to 2013.

Authors:  Gregory A Roth; Mark D Huffman; Andrew E Moran; Valery Feigin; George A Mensah; Mohsen Naghavi; Christopher J L Murray
Journal:  Circulation       Date:  2015-10-27       Impact factor: 29.690

7.  A methodological framework for model selection in interrupted time series studies.

Authors:  J Lopez Bernal; S Soumerai; A Gasparrini
Journal:  J Clin Epidemiol       Date:  2018-06-06       Impact factor: 6.437

8.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

9.  Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries.

Authors:  Margaret E Kruk; Anna D Gage; Naima T Joseph; Goodarz Danaei; Sebastián García-Saisó; Joshua A Salomon
Journal:  Lancet       Date:  2018-09-05       Impact factor: 79.321

10.  Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.

Authors:  Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary N Walsh; Clyde W Yancy
Journal:  J Am Heart Assoc       Date:  2012-02-20       Impact factor: 5.501

View more
  1 in total

1.  Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study.

Authors:  Aishwarya Vijay; Padinhare P Mohanan; Dimple Kondal; Abigail Baldridge; Divin Davies; Raji Devarajan; Govindan Unni; Jabir Abdullakutty; Syam Natesan; Johny Joseph; Pathiyil B Jayagopal; Stigi Joseph; Rajesh Gopinath; Dorairaj Prabhakaran; Mark D Huffman; Anubha Agarwal
Journal:  J Am Heart Assoc       Date:  2021-10-06       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.